#DCLung23 Great overview of antibody drug conjugates by Dr. @KatherineScilla. ADCs targeting #HER3 and #Trop2 being explored without predictive biomarkers; #CEACAM5 and #MET exploring activity in IHC+ cases. Great potential, waiting for more data.
Enjoyed the last 3 days in Chicago at ASCO!! It was great to see friends and colleagues, and learn about some of the exciting advances in cancer care! #ASCO23
Congratulations to @UMGCCC for earning renewal of its prestigious Comprehensive Cancer Center designation for another 5 years - a distinction that places the center in the top echelon of cancer centers nationwide for scientific leadership and research. https://t.co/6Xq2ci3DEV
Proud of our surgeons and all the mesothelioma team at UMGCCC. We are a big group working in getting more opportunities for our pts, including an impressive clinical trials portfolio and translational research @KatherineScilla@RaneeMehra@UMmedschool@curemeso#mesothelioma
Unfortunate biases against lung cancer. Not everyone who smokes gets lung cancer and not everyone who gets lung cancer smokes. And nobody deserves any cancer. #lcsm#lcam